IRADIMED, a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital signs monitoring system that are designed for use during MRI procedures, today announced that it resumed shipments of its MRI compatible patient vital signs monitoring systems into European Commission markets after completing the CE Mark renewal process.
“We are very pleased with obtaining the CE Mark renewal certificate for our patient monitors. With the renewed certificate, we are immediately resuming shipments to the impacted customers and thank them for their patience,” said Leslie McDonnell, President and Chief Executive Officer of the Company.
Source: Company Press Release
